US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Medicus Pharma Ltd.

0.1610

+0.00442.81%

Pre-market: 0.16190.0009+0.56%05:27 EDT

Volume:1.82M

Turnover:294.37K

Market Cap:10.17M

PE:-0.10

High:0.1684

Open:0.1575

Low:0.1550

Close:0.1566

52wk High:2.78

52wk Low:0.1440

Shares:63.18M

Float Shares:46.69M

Volume Ratio:0.98

T/O Rate:3.89%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.6597

EPS(LYR):-2.7356

ROE:-7446.11%

ROA:-110.67%

PB:-5.77

PE(LYR):-0.06

Loading ...

Overview Company News Filings

Medicus Pharma Secures Global Pfizer License for CD228V

Medicus Pharma Surges on Pfizer Licensing Deal for Experimental Cancer Therapy

Medicus Pharma Signs Co-Development, Licensing Deal with Pfizer for Cd228v Antibody-Drug Conjugate

Medicus Pharma - Pays Pfizer $12 Mln Upfront, $15 Mln Due on First Anniversary - SEC Filing

THOMSON REUTERS

Medicus Pharma - Pfizer Paid the Company a One-Time, Non-Refundable Payment of $2.0 Million

THOMSON REUTERS

Medicus Pharma - Enters Co-Development and License Agreement with Pfizer on Sept 2, 2026 - SEC Filing

THOMSON REUTERS

Medicus Pharma Advances SkinJect and Teverelix Amid Financing Gains and Going-Concern Risk

Medicus Pharma Ltd Reports Results for the Quarter Ended June 30 - Earnings Summary

Medicus Pharma Q2 EPS $(0.21) Misses $(0.13) Estimate

Benzinga Earnings

Medicus Pharma Q2 EPS USD -0.21

THOMSON REUTERS

Medicus Pharma Q2 Operating Expenses USD 11.5 Million

THOMSON REUTERS

Medicus Pharma FY26 Q2 Net Loss Widens 89.1% to $11.68 Million

Medicus Pharma Ltd Expected to Post a Loss of 13 Cents a Share - Earnings Preview

Medicus UK Unit Antev Names Faisal Mehmud CEO Effective Aug. 30

Medicus Pharma Appoints DR. Faisal Mehmud as Chief Executive Officer of Antev Limited, United Kingdom

THOMSON REUTERS

Press Release: Medicus Pharma Appoints Dr. Faisal Mehmud as Chief Executive Officer of Antev Limited, United Kingdom

Medicus Pharma - UAE Department of Health Grants Ind Authorization for Precision-E2 Phase 2a Study of Teverelix

THOMSON REUTERS

Medicus Pharma Wins UAE DOH IND Clearance for Teverelix Endometriosis Phase 2a Trial

Medicus Pharma Receives UAE Department of Health (DOH) Authorization to proceed with Novel Prospective Genomics Guided Precision Medicine Study Evaluating Teverelix® in Women with Endometriosis

Medicus Pharma gets FDA green light for SkinJect Phase 2b Gorlin study

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/MDCX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MDCX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDCX\",,,,,undefined,":{"symbol":"MDCX","market":"US","secType":"STK","nameCN":"Medicus Pharma Ltd.","latestPrice":0.161,"timestamp":1790798400000,"preClose":0.1566,"halted":0,"volume":1815703,"hourTrading":{"tag":"盘前","latestPrice":0.1619,"preClose":0.161,"latestTime":"05:27 EDT","volume":3613,"amount":574.68038378,"timestamp":1790846838346,"change":0.0009,"changeRate":0.00559,"amplitude":0.060248},"delay":0,"changeRate":0.028097062579821298,"floatShares":46686672,"shares":63180600,"eps":-1.659689,"marketStatus":"Pre-Mkt","change":0.0044,"latestTime":"10-01 05:42:07 EDT","open":0.1575,"high":0.1684,"low":0.155,"amount":294374.31686773,"amplitude":0.085568,"askPrice":0.1758,"askSize":100,"bidPrice":0.158,"bidSize":300,"shortable":3,"etf":0,"ttmEps":-1.659689,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790861400000},"marketStatusCode":1,"adr":0,"listingDate":1731560400000,"exchange":"NASDAQ","adjPreClose":0.161,"preHourTrading":{"tag":"盘前","latestPrice":0.1619,"preClose":0.161,"latestTime":"05:27 EDT","volume":3613,"amount":574.68038378,"timestamp":1790846838346,"change":0.0009,"changeRate":0.00559,"amplitude":0.060248},"postHourTrading":{"tag":"盘后","latestPrice":0.16,"preClose":0.161,"latestTime":"19:56 EDT","volume":70159,"amount":11318.3041,"timestamp":1790812574511,"change":-0.001,"changeRate":-0.006211,"amplitude":0.043478},"volumeRatio":0.9788507354559403},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDCX\",,,,,undefined,":{"symbol":"MDCX","floatShares":46686672,"roa":"-110.67%","roe":"-7446.11%","lyrEps":-2.735593,"volumeRatio":0.9788507354559403,"shares":63180600,"dividePrice":0,"high":0.1684,"amplitude":0.085568,"preClose":0.1566,"low":0.155,"week52Low":0.144,"pbRate":"-5.77","week52High":2.78,"institutionHeld":0,"latestPrice":0.161,"committee":0.5,"eps":-1.659689,"divideRate":0,"volume":1815703,"delay":0,"ttmEps":-1.659689,"open":0.1575,"prevYearClose":1.53,"prevWeekClose":0.1524,"prevMonthClose":0.161,"prevQuarterClose":0.161,"fiveDayClose":0.1594,"twentyDayClose":0.2512,"sixtyDayClose":0.44},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MDCX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"MDCX","fiscalQuarterEnding":"2026/06","expectedEps":-0.14,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"post","actualEps":-0.21},{"market":"US","date":"2026-05-14","symbol":"MDCX","fiscalQuarterEnding":"2026/03","expectedEps":-0.18,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778731200000,"reportTimeType":"post","actualEps":-0.31},{"market":"US","date":"2026-03-25","symbol":"MDCX","fiscalQuarterEnding":"2025/12","expectedEps":-0.32,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774411200000,"reportTimeType":"post","actualEps":-0.82},{"date":"2025-11-14","symbol":"MDCX","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1763154000000,"name":null,"time":"Post-Mkt","dateTimestamp":1763096400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MDCX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MDCX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1785297600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MDCX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MDCX","date":"2026-09-29","current":-0.097006,"percent":0.99635,"low":-3.23298,"twenty":-2.115799,"median":-0.506062,"eighty":-0.311804,"high":-0.169596,"avg":-1.037434,"sd":0.945416,"marketCap":9609770},"quantilePoints":[{"date":"2025-08-29","current":-2.084531,"twenty":-2.272139,"median":-2.126221,"eighty":-2.109545,"marketCap":35632532},{"date":"2025-09-05","current":-1.907346,"twenty":-2.205434,"median":-2.115799,"eighty":-2.053263,"marketCap":32603766},{"date":"2025-09-12","current":-2.345097,"twenty":-2.211687,"median":-2.12101,"eighty":-2.053263,"marketCap":40086598},{"date":"2025-09-19","current":-2.532705,"twenty":-2.511859,"median":-2.178335,"eighty":-2.080362,"marketCap":43293526},{"date":"2025-09-26","current":-2.817408,"twenty":-2.759151,"median":-2.287772,"eighty":-2.103292,"marketCap":48160186},{"date":"2025-10-03","current":-3.005474,"twenty":-2.869667,"median":-2.511859,"eighty":-2.115799,"marketCap":51374941},{"date":"2025-10-10","current":-3.005474,"twenty":-2.994879,"median":-2.558762,"eighty":-2.122052,"marketCap":51374941},{"date":"2025-10-17","current":-2.885734,"twenty":-2.976858,"median":-2.720313,"eighty":-2.151236,"marketCap":49328130},{"date":"2025-10-24","current":-2.909682,"twenty":-2.974342,"median":-2.774974,"eighty":-2.174166,"marketCap":49737492},{"date":"2025-10-31","current":-2.957578,"twenty":-2.974342,"median":-2.817408,"eighty":-2.178335,"marketCap":50556216},{"date":"2025-11-07","current":-2.897708,"twenty":-2.962368,"median":-2.809662,"eighty":-2.228364,"marketCap":49532811},{"date":"2025-11-14","current":-2.706124,"twenty":-2.950394,"median":-2.817408,"eighty":-2.292984,"marketCap":46257915},{"date":"2025-11-21","current":-1.28141,"twenty":-2.950394,"median":-2.789942,"eighty":-2.178335,"marketCap":44939453},{"date":"2025-11-28","current":-1.355609,"twenty":-2.936025,"median":-2.763,"eighty":-2.119968,"marketCap":48464116},{"date":"2025-12-05","current":-1.183077,"twenty":-2.916866,"median":-2.742046,"eighty":-2.04284,"marketCap":42295956},{"date":"2025-12-12","current":-1.201563,"twenty":-2.904892,"median":-2.700137,"eighty":-1.376181,"marketCap":42956830},{"date":"2025-12-19","current":-1.022869,"twenty":-2.897708,"median":-2.63428,"eighty":-1.31987,"marketCap":36568379},{"date":"2025-12-26","current":-0.955088,"twenty":-2.897553,"median":-2.584818,"eighty":-1.266827,"marketCap":34145173},{"date":"2026-01-02","current":-1.074791,"twenty":-2.896932,"median":-2.511859,"eighty":-1.220048,"marketCap":38424640},{"date":"2026-01-09","current":-1.095865,"twenty":-2.885734,"median":-2.329463,"eighty":-1.179996,"marketCap":39178064},{"date":"2026-01-16","current":-0.976444,"twenty":-2.885734,"median":-2.178335,"eighty":-1.123965,"marketCap":34908660},{"date":"2026-01-23","current":-0.94132,"twenty":-2.866576,"median":-2.167912,"eighty":-1.101485,"marketCap":33652952},{"date":"2026-01-30","current":-0.878097,"twenty":-2.861786,"median":-2.115799,"eighty":-1.061072,"marketCap":31392680},{"date":"2026-02-06","current":-0.765701,"twenty":-2.861786,"median":-2.074108,"eighty":-1.022014,"marketCap":27374416},{"date":"2026-02-13","current":-0.709738,"twenty":-2.853549,"median":-1.933403,"eighty":-0.974021,"marketCap":25373688},{"date":"2026-02-20","current":-0.786136,"twenty":-2.850483,"median":-1.381324,"eighty":-0.961937,"marketCap":28104981},{"date":"2026-02-27","current":-0.97195,"twenty":-2.849812,"median":-1.344224,"eighty":-0.949581,"marketCap":34747976},{"date":"2026-03-06","current":-0.484474,"twenty":-2.849812,"median":-1.300152,"eighty":-0.949581,"marketCap":17320333},{"date":"2026-03-13","current":-0.412761,"twenty":-2.835443,"median":-1.263181,"eighty":-0.891018,"marketCap":14756541},{"date":"2026-03-20","current":-0.412761,"twenty":-2.825864,"median":-1.220048,"eighty":-0.847322,"marketCap":14756541},{"date":"2026-03-27","current":-0.387698,"twenty":-2.82079,"median":-1.201563,"eighty":-0.836077,"marketCap":18330934},{"date":"2026-04-02","current":-0.349652,"twenty":-2.811211,"median":-1.179996,"eighty":-0.820403,"marketCap":16532085},{"date":"2026-04-10","current":-0.367967,"twenty":-2.792337,"median":-1.125793,"eighty":-0.786136,"marketCap":17398052},{"date":"2026-04-17","current":-0.250001,"twenty":-2.775573,"median":-1.109135,"eighty":-0.744685,"marketCap":11820441},{"date":"2026-04-24","current":-0.276475,"twenty":-2.764797,"median":-1.099378,"eighty":-0.508201,"marketCap":13072156},{"date":"2026-05-01","current":-0.235266,"twenty":-2.75402,"median":-1.088841,"eighty":-0.417566,"marketCap":11123732},{"date":"2026-05-08","current":-0.277717,"twenty":-2.74923,"median":-1.069002,"eighty":-0.412761,"marketCap":13130880},{"date":"2026-05-15","current":-0.393186,"twenty":-2.733353,"median":-1.041354,"eighty":-0.401798,"marketCap":18590424},{"date":"2026-05-22","current":-0.308017,"twenty":-2.714637,"median":-1.024243,"eighty":-0.38811,"marketCap":15777036},{"date":"2026-05-29","current":-0.354651,"twenty":-2.703729,"median":-1.018593,"eighty":-0.376126,"marketCap":18165658},{"date":"2026-06-05","current":-0.402361,"twenty":-2.691755,"median":-0.976444,"eighty":-0.374724,"marketCap":20609444},{"date":"2026-06-12","current":-0.35842,"twenty":-2.672597,"median":-0.968141,"eighty":-0.372398,"marketCap":18358733},{"date":"2026-06-18","current":-0.378775,"twenty":-2.63428,"median":-0.962395,"eighty":-0.367967,"marketCap":19401342},{"date":"2026-06-26","current":-0.492235,"twenty":-2.63428,"median":-0.955088,"eighty":-0.371628,"marketCap":25212882},{"date":"2026-07-02","current":-0.442458,"twenty":-2.59471,"median":-0.94132,"eighty":-0.37203,"marketCap":22663265},{"date":"2026-07-10","current":-0.467347,"twenty":-2.543128,"median":-0.915037,"eighty":-0.3732,"marketCap":23938074},{"date":"2026-07-17","current":-0.449095,"twenty":-2.516028,"median":-0.871896,"eighty":-0.374395,"marketCap":23003214},{"date":"2026-07-24","current":-0.424981,"twenty":-2.511859,"median":-0.846653,"eighty":-0.374627,"marketCap":21768066},{"date":"2026-07-31","current":-0.290474,"twenty":-2.411802,"median":-0.843141,"eighty":-0.371929,"marketCap":14878433},{"date":"2026-08-07","current":-0.34025,"twenty":-2.326336,"median":-0.835949,"eighty":-0.363051,"marketCap":17428051},{"date":"2026-08-14","current":-0.353971,"twenty":-2.282561,"median":-0.821824,"eighty":-0.360424,"marketCap":20056990},{"date":"2026-08-21","current":-0.30351,"twenty":-2.211687,"median":-0.793282,"eighty":-0.354379,"marketCap":17197762},{"date":"2026-08-28","current":-0.298604,"twenty":-2.178335,"median":-0.778989,"eighty":-0.346389,"marketCap":16919767},{"date":"2026-09-04","current":-0.190112,"twenty":-2.172081,"median":-0.757549,"eighty":-0.339549,"marketCap":10772294},{"date":"2026-09-11","current":-0.179965,"twenty":-2.151236,"median":-0.709738,"eighty":-0.335,"marketCap":10197350},{"date":"2026-09-18","current":-0.190224,"twenty":-2.122052,"median":-0.541685,"eighty":-0.329543,"marketCap":10778612},{"date":"2026-09-25","current":-0.177066,"twenty":-2.115799,"median":-0.506615,"eighty":-0.313898,"marketCap":10033080},{"date":"2026-09-29","current":-0.169596,"twenty":-2.115799,"median":-0.506062,"eighty":-0.311804,"marketCap":9609770}],"updateTime":1790825321028},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MDCX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664872495","title":"Medicus Pharma Secures Global Pfizer License for CD228V","url":"https://stock-news.laohu8.com/highlight/detail?id=2664872495","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664872495?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:51","pubTimestamp":1788439897,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd ( ($MDCX) ) just unveiled an update. On September 2, 2026, Medicus Pharma Ltd., via Medicus Pharma Inc., entered a co-developmen...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/medicus-pharma-secures-global-pfizer-license-for-cd228v?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/medicus-pharma-secures-global-pfizer-license-for-cd228v?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MDCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664749708","title":"Medicus Pharma Surges on Pfizer Licensing Deal for Experimental Cancer Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2664749708","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664749708?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:25","pubTimestamp":1788438356,"startTime":"0","endTime":"0","summary":"BUZZ-Medicus Pharma surges on Pfizer licensing deal for experimental cancer therapy** Shares of drug developer Medicus PharmaMDCX.Ojump 19.3% to 31 cents premarket** Co says in a regulatory filing that it has entered into a license agreement with PfizerPFE.Nfor rights to develop and commercialize an experimental cancer therapy** Under the deal, Pfizer is eligible to receive more than $1 billion in development, regulatory and sales-based milestone payments, as well as tiered low double-digit royalties on net sales** Pfizer granted Medicus an exclusive global license to develop, manufacture and commercialize PF-08046031, also known as CD228V, an early-stage antibody-drug conjugate targeting melanotransferrin  for all human diseases and disorders** As part of the agreement, Medicus paid Pfizer a non-refundable upfront fee of $12 million and will make an additional $15 million payment on the first anniversary of the deal** Pfizer, in turn, paid Medicus $2 million that must be used to suppo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nL4N44V0XU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225771236.USD","LU0985481810.HKD","BK4581","BK4534","LU0225284248.USD","SG9999003800.SGD","IE00B3T34201.USD","IE000M9KFDE8.USD","IE00B19Z3581.USD","LU0306807586.USD","IE00BBT3K403.USD","BK4592","SG9999011175.SGD","BK4550","PFE","IE0002270589.USD","LU0456855351.SGD","LU0321505868.SGD","BK4588","IE00B19Z3B42.SGD","SG9999002224.SGD","LU1883839398.USD","LU2596442595.SGD","BK4599","OZEM","LU0170899867.USD","LU0122379950.USD","LU0868494617.USD","LU1066053197.SGD","BK4007","MDCX","LU0289739699.SGD","LU0306806265.USD","LU1057294990.SGD","LU1066051498.USD","BK4568","IE00BLSP4452.SGD","LU1894683348.USD","BK4533","BK4585","LU0234572021.USD","SG9999001176.SGD","SG9999001176.USD","SG9999002232.USD","SGXZ57979304.SGD","LU1023059063.AUD","LU0321505439.SGD","BK4139","LU1894683264.USD","SG9999013999.USD","IE00BLSP4239.USD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664287179","title":"Medicus Pharma Signs Co-Development, Licensing Deal with Pfizer for Cd228v Antibody-Drug Conjugate","url":"https://stock-news.laohu8.com/highlight/detail?id=2664287179","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664287179?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:04","pubTimestamp":1788437065,"startTime":"0","endTime":"0","summary":"Medicus Pharma signs co-development, licensing deal with Pfizer for CD228V antibody-drug conjugateMedicus Pharma entered a co-development and license deal with Pfizer for PF-08046031 (CD228V), an earl","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL3Mtg02:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1057294990.SGD","LU1883839398.USD","SGXZ57979304.SGD","SG9999011175.SGD","IE00B19Z3581.USD","LU0456855351.SGD","SG9999013999.USD","LU0122379950.USD","BK4599","LU1894683264.USD","BK4585","LU1066051498.USD","LU0321505868.SGD","LU2596442595.SGD","BK4588","BK4007","LU0321505439.SGD","BK4533","IE00B3T34201.USD","BK4581","IE00BLSP4452.SGD","LU0234572021.USD","MDCX","BK4592","SG9999001176.SGD","SG9999003800.SGD","LU0868494617.USD","LU0306807586.USD","LU0225771236.USD","LU0306806265.USD","LU0985481810.HKD","BK4568","PFE","BK4534","OZEM","SG9999002232.USD","IE00BLSP4239.USD","LU0170899867.USD","LU1894683348.USD","LU1066053197.SGD","BK4139","SG9999002224.SGD","BK4550","IE00B19Z3B42.SGD","LU0289739699.SGD","IE00BBT3K403.USD","LU0225284248.USD","LU1023059063.AUD","IE0002270589.USD","SG9999001176.USD","LU0058720904.USD","IE000M9KFDE8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664763871","title":"Medicus Pharma - Pays Pfizer $12 Mln Upfront, $15 Mln Due on First Anniversary - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664763871","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664763871?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:03","pubTimestamp":1788437008,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nFWN44V0PD:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B3T34201.USD","LU0306806265.USD","SG9999013999.USD","BK4592","LU1894683348.USD","LU1066053197.SGD","MDCX","IE0002270589.USD","IE00B19Z3B42.SGD","OZEM","LU2596442595.SGD","LU1894683264.USD","LU1023059063.AUD","IE00BBT3K403.USD","IE00BLSP4452.SGD","LU0456855351.SGD","LU1066051498.USD","SG9999002232.USD","BK4007","LU0170899867.USD","LU0321505868.SGD","LU1883839398.USD","SG9999001176.SGD","BK4533","LU0321505439.SGD","BK4585","BK4139","BK4534","LU1057294990.SGD","LU0868494617.USD","SG9999001176.USD","LU0058720904.USD","LU0985481810.HKD","BK4581","BK4599","SG9999002224.SGD","LU0234572021.USD","IE00B19Z3581.USD","PFE","IE00BLSP4239.USD","SG9999011175.SGD","LU0122379950.USD","LU0306807586.USD","BK4550","LU0225284248.USD","SG9999003800.SGD","SGXZ57979304.SGD","BK4588","LU0289739699.SGD","LU0225771236.USD","BK4568","IE000M9KFDE8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664717788","title":"Medicus Pharma - Pfizer Paid the Company a One-Time, Non-Refundable Payment of $2.0 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2664717788","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664717788?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:03","pubTimestamp":1788437008,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nFWN44V0PD:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE000M9KFDE8.USD","BK4534","LU0456855351.SGD","LU1057294990.SGD","BK4139","LU0289739699.SGD","SGXZ57979304.SGD","BK4592","LU0122379950.USD","BK4550","IE00BBT3K403.USD","SG9999002232.USD","BK4599","IE0002270589.USD","LU0234572021.USD","SG9999001176.SGD","SG9999011175.SGD","LU0321505439.SGD","BK4568","MDCX","SG9999001176.USD","LU2596442595.SGD","LU0170899867.USD","SG9999002224.SGD","LU0058720904.USD","LU1066053197.SGD","LU1883839398.USD","BK4588","IE00B19Z3B42.SGD","LU0306806265.USD","LU1894683264.USD","LU0985481810.HKD","IE00B19Z3581.USD","IE00BLSP4239.USD","LU0868494617.USD","BK4007","LU0225771236.USD","BK4533","OZEM","LU0306807586.USD","LU1023059063.AUD","PFE","LU0225284248.USD","SG9999003800.SGD","LU1894683348.USD","BK4585","BK4581","IE00B3T34201.USD","LU1066051498.USD","SG9999013999.USD","IE00BLSP4452.SGD","LU0321505868.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664205871","title":"Medicus Pharma - Enters Co-Development and License Agreement with Pfizer on Sept 2, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664205871","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664205871?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:03","pubTimestamp":1788437008,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nFWN44V0PD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999003800.SGD","OZEM","LU0306807586.USD","BK4007","IE00B3T34201.USD","LU1057294990.SGD","LU1894683348.USD","IE000M9KFDE8.USD","BK4592","LU0122379950.USD","LU0306806265.USD","IE00BLSP4239.USD","BK4550","BK4534","LU1883839398.USD","LU0170899867.USD","LU0868494617.USD","LU1023059063.AUD","SG9999001176.SGD","LU0225284248.USD","BK4588","BK4581","LU0321505868.SGD","LU1066051498.USD","PFE","IE00BLSP4452.SGD","IE00B19Z3B42.SGD","LU0058720904.USD","SG9999013999.USD","MDCX","BK4568","LU0985481810.HKD","LU1894683264.USD","BK4139","SG9999002232.USD","IE0002270589.USD","BK4533","LU2596442595.SGD","LU0321505439.SGD","LU0456855351.SGD","IE00BBT3K403.USD","SG9999002224.SGD","SG9999011175.SGD","SG9999001176.USD","LU0234572021.USD","BK4599","LU0289739699.SGD","LU1066053197.SGD","IE00B19Z3581.USD","BK4585","LU0225771236.USD","SGXZ57979304.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659186988","title":"Medicus Pharma Advances SkinJect and Teverelix Amid Financing Gains and Going-Concern Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2659186988","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659186988?lang=en_us&edition=fundamental","pubTime":"2026-08-13 06:37","pubTimestamp":1786574244,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd ( ($MDCX) ) has shared an update. Medicus Pharma reported second quarter 2026 results that reflected its evolution into a divers...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/medicus-pharma-advances-skinject-and-teverelix-amid-financing-gains-and-going-concern-risk?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/medicus-pharma-advances-skinject-and-teverelix-amid-financing-gains-and-going-concern-risk?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659918658","title":"Medicus Pharma Ltd Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2659918658","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659918658?lang=en_us&edition=fundamental","pubTime":"2026-08-13 06:34","pubTimestamp":1786574083,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd reports results for the quarter ended June 30 - Earnings SummaryMedicus Pharma LtdMDCX.OQreported a quarterly adjusted loss of 21 cents per share for the quarter ended June 30, high","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL8N4492BL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659918525","title":"Medicus Pharma Q2 EPS $(0.21) Misses $(0.13) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2659918525","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659918525?lang=en_us&edition=fundamental","pubTime":"2026-08-13 06:02","pubTimestamp":1786572157,"startTime":"0","endTime":"0","summary":"Medicus Pharma (NASDAQ:MDCX) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.13) by 61.54 percent. This is a 51.16 percent increase over losses of $(0.43) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61162933/medicus-pharma-q2-eps-0-21-misses-0-13-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Medicus Pharma Q2 EPS $(0.21) Misses $(0.13) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659854111","title":"Medicus Pharma Q2 EPS USD -0.21","url":"https://stock-news.laohu8.com/highlight/detail?id=2659854111","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659854111?lang=en_us&edition=fundamental","pubTime":"2026-08-13 06:00","pubTimestamp":1786572023,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nPLXZX85SN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659185419","title":"Medicus Pharma Q2 Operating Expenses USD 11.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659185419","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659185419?lang=en_us&edition=fundamental","pubTime":"2026-08-13 06:00","pubTimestamp":1786572023,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nPLXZX85SN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MDCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659424183","title":"Medicus Pharma FY26 Q2 Net Loss Widens 89.1% to $11.68 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659424183","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659424183?lang=en_us&edition=fundamental","pubTime":"2026-08-13 05:21","pubTimestamp":1786569697,"startTime":"0","endTime":"0","summary":"Medicus Pharma FY26 Q2 net loss widens 89.1% to $11.68 millionMedicus Pharma posted a Q2 net loss of USD 11.68 million, widening from USD 6.18 million a year earlier.Operating loss widened to USD 11.48 million as total operating expenses rose 90.8% to USD 11.48 million.General and administrative costs climbed 43.6% to USD 6.57 million; R&D spending more than doubled to USD 4.91 million.Cash and cash equivalents were USD 15.17 million at June 30, with USD 10.02 million of restricted cash and working capital of USD 6.14 million.FDA issued a “Study May Proceed” letter for SkinJect’s SKNJCT-005 Phase 2b registrational trial; UAE DOH authorized Teverelix PRECISION-E2 Phase 2a.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medicus Pharma Ltd","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDLcdLr7D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MDCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657290136","title":"Medicus Pharma Ltd Expected to Post a Loss of 13 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2657290136","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657290136?lang=en_us&edition=fundamental","pubTime":"2026-08-08 05:35","pubTimestamp":1786138521,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd <MDCX.OQ> expected to post a loss of13cents a share - Earnings PreviewMedicus Pharma LtdMDCX.OQMDCX.Ois expected to  show no change in quarterly revenue when it reports  results on ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL8N4442LF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656375917","title":"Medicus UK Unit Antev Names Faisal Mehmud CEO Effective Aug. 30","url":"https://stock-news.laohu8.com/highlight/detail?id=2656375917","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656375917?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:30","pubTimestamp":1785756631,"startTime":"0","endTime":"0","summary":"Medicus UK unit Antev names Faisal Mehmud CEO effective Aug. 30Medicus’ UK subsidiary Antev named Faisal Mehmud CEO, effective Aug. 30, 2026.Mehmud keeps roles as Medicus chief medical officer, Antev ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL9Bf2Kx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2210150020.SGD","LU2095319765.USD","MDCX","NDAQ","IE00BN0W2T93.GBP","SG9999014021.USD","BK4588","SG9999014013.SGD","IE00B3QW5Z07.USD","LU0314104364.USD","IE00BN0W2W23.USD","LU2210149790.SGD","IE00BN0W2V16.EUR","BK4112","SG9999014005.SGD","IE00BGHQF748.EUR","BK4139","BCDF","IE00BKPKM429.USD","SG9999014039.USD","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656375980","title":"Medicus Pharma Appoints DR. Faisal Mehmud as Chief Executive Officer of Antev Limited, United Kingdom","url":"https://stock-news.laohu8.com/highlight/detail?id=2656375980","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656375980?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:30","pubTimestamp":1785756600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nTUA8KSWWB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MDCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656375165","title":"Press Release: Medicus Pharma Appoints Dr. Faisal Mehmud as Chief Executive Officer of Antev Limited, United Kingdom","url":"https://stock-news.laohu8.com/highlight/detail?id=2656375165","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656375165?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:30","pubTimestamp":1785756600,"startTime":"0","endTime":"0","summary":"PHILADELPHIA, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (\"Medicus\" or the \"Company\"), a biotech/life sciences company focused on advancing the clinical development programs ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4205","BK4232","BK4528","BCC","BK4104","BK4567","BK4139","UBCP","BK4233","MDCX","UK","MRCP","BK4022","BK4211","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655363165","title":"Medicus Pharma - UAE Department of Health Grants Ind Authorization for Precision-E2 Phase 2a Study of Teverelix","url":"https://stock-news.laohu8.com/highlight/detail?id=2655363165","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655363165?lang=en_us&edition=fundamental","pubTime":"2026-07-31 19:30","pubTimestamp":1785497426,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nFWN43X0OR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655363467","title":"Medicus Pharma Wins UAE DOH IND Clearance for Teverelix Endometriosis Phase 2a Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2655363467","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655363467?lang=en_us&edition=fundamental","pubTime":"2026-07-31 19:30","pubTimestamp":1785497424,"startTime":"0","endTime":"0","summary":"Medicus Pharma wins UAE DOH IND clearance for Teverelix endometriosis Phase 2a trialMedicus Pharma won UAE Department of Health IND clearance to start the PRECISION-E2 Phase 2a Teverelix study in mode","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nNDL1jRj2g:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","BK4588","BK4139","BK4112","BCDF","SG9999014039.USD","LU2210149790.SGD","LU0314104364.USD","SG9999014021.USD","IE00BGHQF748.EUR","BK4585","SG9999014005.SGD","IE00BKPKM429.USD","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","NDAQ","IE00BN0W2V16.EUR","LU2210150020.SGD","MDCX","SG9999014013.SGD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655632143","title":"Medicus Pharma Receives UAE Department of Health (DOH) Authorization to proceed with Novel Prospective Genomics Guided Precision Medicine Study Evaluating Teverelix® in Women with Endometriosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2655632143","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655632143?lang=en_us&edition=fundamental","pubTime":"2026-07-31 19:30","pubTimestamp":1785497400,"startTime":"0","endTime":"0","summary":"Randomized Phase 2a PRECISION-E2 study designed to evaluate a predefined panel of genes to advance personalized medicine in women's healthPHILADELPHIA, July  31, 2026  (GLOBE NEWSWIRE) -- Medicus Phar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/31/3336735/0/en/Medicus-Pharma-Receives-UAE-Department-of-Health-DOH-Authorization-to-proceed-with-Novel-Prospective-Genomics-Guided-Precision-Medicine-Study-Evaluating-Teverelix-in-Women-with-End.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B1BXHZ80.USD","BK4006","BK4567","BCC","IE00BZ1G4Q59.USD","LU0170899867.USD","LU0971096721.USD","BK4139","UAE","LU2237443622.USD","IE00BFXG1179.USD","CMC","LU2237443895.HKD","LU0267386448.USD","LU2746668461.USD","LU0882574139.USD","LU2237443978.SGD","LU2237443549.SGD","IE00BHPRN162.USD","LU2237443382.USD","LU1363072403.SGD","LU2746668974.SGD","MDCX","BK4104","LU0149725797.USD","IE00BKVL7J92.USD","LU2237443465.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654322043","title":"Medicus Pharma gets FDA green light for SkinJect Phase 2b Gorlin study","url":"https://stock-news.laohu8.com/highlight/detail?id=2654322043","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654322043?lang=en_us&edition=fundamental","pubTime":"2026-07-27 21:10","pubTimestamp":1785157848,"startTime":"0","endTime":"0","summary":"Medicus Pharma (MDCX) announced the FDA has completed its safety review of the company’s Investigational New Drug application for SKNJCT-005 and is...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/medicus-pharma-gets-fda-green-light-for-skinject-phase-2b-gorlin-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/medicus-pharma-gets-fda-green-light-for-skinject-phase-2b-gorlin-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4139","LABU","MDCX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":93,"code":"91000000","status":"200"}]}}